These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 11377521

  • 21. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
    Marcus N, Khaghani A, Burke M, Yacoub M, Banner N.
    Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
    [No Abstract] [Full Text] [Related]

  • 22. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
    Ringe B, Braun F, Wietzke P, Oellerich M, Ramadori G.
    Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
    [No Abstract] [Full Text] [Related]

  • 23. Reduction of early rejection in adult liver transplantation with ATG induction therapy.
    Schulak J, May E, Post A, Fasola C, Mulligan D, Sterling R.
    Transplant Proc; 1997 Nov; 29(1-2):555-6. PubMed ID: 9123126
    [No Abstract] [Full Text] [Related]

  • 24. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
    McDiarmid S, Goss J, Seu P, Shackleton C, Vargas J, Ament M, Busuttil R.
    Transplant Proc; 1998 Jun; 30(4):1397-8. PubMed ID: 9636564
    [No Abstract] [Full Text] [Related]

  • 25. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
    Platz KP, Tullius SG, Mueller AR, Schumacher G, Nüssler N, Neuhaus R, Bechstein WO, Lobeck H, Neuhaus P.
    Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
    [No Abstract] [Full Text] [Related]

  • 26. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M, Neumann U, Knoop M, Bechstein WO, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract] [Full Text] [Related]

  • 27. Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept.
    Carl S, Dörsam J, Mandelbaum A, Staehler G, Wiesel M.
    Transplant Proc; 1998 Jun; 30(4):1236-7. PubMed ID: 9636502
    [No Abstract] [Full Text] [Related]

  • 28. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 29. Low rejection rates with tacrolimus-based dual and triple regimens following liver transplantation.
    Boillot O, Baulieux J, Wolf P, Messner M, Cherqui D, Gugenheim J, Pageaux G, Belghiti J, Calmus Y, Le Treut Y, Neau-Cransac M, Samuel D.
    Clin Transplant; 2001 Jun; 15(3):159-66. PubMed ID: 11389705
    [Abstract] [Full Text] [Related]

  • 30. Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial.
    Neuhaus P, Klupp J, Langrehr JM, Neumann U, Gebhardt A, Pratschke J, Tullius SG, Lohmann R, Radke C, Rayes N, Neuhaus R, Bechstein WO.
    Transplantation; 2000 Jun 15; 69(11):2343-53. PubMed ID: 10868638
    [Abstract] [Full Text] [Related]

  • 31. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J, Ortuño J, Spanish and Italian Tacrolimus Study Group.
    Transplant Proc; 2002 Feb 15; 34(1):89-91. PubMed ID: 11959198
    [No Abstract] [Full Text] [Related]

  • 32. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
    Platz KP, Mueller AR, Willimski C, Mansoorian B, Berg T, Neuhaus R, Hopf U, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun 15; 30(4):1468-9. PubMed ID: 9636596
    [No Abstract] [Full Text] [Related]

  • 33. Liver transplantation from cadaveric and living donors.
    Lo CM, Lo RJ, Lai CL, Fan ST, Wong J.
    Transplant Proc; 1996 Jun 15; 28(3):1659-60. PubMed ID: 8658826
    [No Abstract] [Full Text] [Related]

  • 34. Is the use of marginal liver grafts justified?
    Mueller AR, Platz KP, Krause P, Steinmüller T, Glanemann M, Neumann U, Lobeck H, Neuhaus P.
    Transplant Proc; 1999 Jun 15; 31(1-2):401-2. PubMed ID: 10083160
    [No Abstract] [Full Text] [Related]

  • 35. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
    Platz KP, Mueller AR, Neuhaus R, Keck HH, Lobeck H, Neuhaus P.
    Transplant Proc; 1997 Nov 15; 29(7):2872-4. PubMed ID: 9365598
    [No Abstract] [Full Text] [Related]

  • 36. Combined liver-kidney transplantation: long-term follow-up in 18 patients.
    Lang M, Kahl A, Bechstein WO, Neumann U, Settmacher U, Frei U, Neuhaus P.
    Transplant Proc; 1998 Aug 15; 30(5):1865-7. PubMed ID: 9723313
    [No Abstract] [Full Text] [Related]

  • 37. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A.
    Transplant Proc; 1999 Aug 15; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract] [Full Text] [Related]

  • 38. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JW, Lake J.
    Transplant Proc; 1993 Feb 15; 25(1 Pt 1):679-88. PubMed ID: 7679840
    [Abstract] [Full Text] [Related]

  • 39. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K, Saito K, Sonda K, Nakagawa Y, Katagiri A, Tomita Y, Tanigawa T, Takeda M.
    Transplant Proc; 1998 Jun 15; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract] [Full Text] [Related]

  • 40. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P, Samonakis D, Cholongitas E, Patch D, O'Beirne J, Dhillon AP, Rolles K, McCormick A, Hayes P, Burroughs AK.
    Liver Transpl; 2009 Dec 15; 15(12):1783-91. PubMed ID: 19938143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.